[8th April 2026]

This year, we are shining a spotlight on the members of our Medical Advisory Panel. As the first in this series, we are pleased to highlight Professor Sara Faithfull, PhD, MSc, BSc (Hons), RN.

Why we have a Medical Advisory Panel 

Our Medical Advisory Panel brings together leading clinicians and researchers from across the UK and Ireland who share a commitment to improving care for people affected by Pelvic Radiation Disease (PRD). Their expertise helps ensure that our guidance and resources are clinically robust, evidence-based, and aligned with best practice, with each member contributing unique insight to our work.

About Professor Faithfull

Professor Faithfull is an Adjunct Professor at Trinity College Dublin, School of Medicine, Discipline of Radiation Therapy, Ireland, and a Visiting Professor in ‘Transforming cancer OUtcomes through Research’ (TOUR), Centre for Cancer, Society and Public Health, Department of Precision and Population Oncology, School of Cancer and Pharmaceutical Studies, King’s College London, UK. She trained as a cancer nurse in 1986 at the Royal Marsden Hospital (UK) and has worked in oncology for the past 37 years.

Professor Faithfull completed her BSc after qualifying as a nurse and was awarded the Smith and Nephew Nursing Fellowship in 1991 and a Cancer Research UK Research Fellowship in 1994. She obtained her PhD in Supportive Care in Radiotherapy at the Institute of Cancer Research, London in 2000 and has held positions at The Royal Marsden Hospital NHS Foundation Trust, The Institute of Cancer Research, and the University of Surrey.

Professor Faithfull’s research interest is in late effects of cancer treatment and the impact these have on people living with and beyond cancer, specialising in PRD and supported self-management for men with prostate cancer.

We are proud to have Professor Faithfull’s extensive clinical experience, research expertise, and insight as part of our Medical Advisory Panel. Her work continues to strengthen the PRDA’s mission to provide evidence-based, patient-focused guidance and support for both healthcare professionals and people living with the long-term effects of pelvic radiotherapy.